Pharmaceutical products

Contract Value:: GBP 240M - 240M
Notice Type:: Contract award notice

Published Date:: 31 May 2017
Closing Date:

Location(s):: UK UNITED KINGDOM

Description:

Invitation to offer for NHS National Pharmaceuticals — Wave 10c

Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months.

Potential periods of call-offs under the framework agreement: Oral Products: All Regions 1.7./2017 to 28.2.2019 (20 months) Hospital Only Products: Central and South West (CESW) 1.7.2017 to 30.6.2018 (12 months); North West and Eastern and North London (NWLN) 1.7.2017 to 30.6.2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 1.7.2017 to 30.6.2018 (12 months).

Wave 10c — Oral Products: All Regions

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months.

Potential periods of call-offs under the framework agreement: Oral Products: All Regions 1.7.2017 to 28.2.2019 (20 months).

Wave 10c — Hospital Only Products: CESW

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 24 months.

Potential periods of call-offs under the framework agreement: Hospital Only Products: Central and South West (CESW) 1.7.2017 to 30.6.2018 (12 months).

Wave 10c — Hospital Only Products: LSNE

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 24 months.

Potential periods of call-offs under the framework agreement: Hospital Only Products: South East and South London and North East and Yorkshire (LSNE) 1.7.2017 to 30.6.2018 (12 months).

Wave 10c — Hospital Only Products: NWLN

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 24 months.

Potential periods of call-offs under the framework agreement: Hospital Only Products: North West and Eastern and North London (NWLN) 1.7.2017 to 30.6.2018 (12 months).

Awarded to:: NHS National Pharmaceuticals — Wave 10c; Please see section VI.3), Please see section VI.3) (UK)

: Download full details as .pdf

The Buyer:: The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)

CPV Code(s):: 33600000 - Pharmaceutical products